Better Evidence and Translation for Calciphylaxis
This global platform study will evaluate multiple interventions, across several domains of therapeutic care, in adult patients with kidney failure and newly diagnosed calciphylaxis.
| Condition(s) | Calciphylaxis |
|---|---|
| Status | Recruiting |
| Phase | Phase 3 |
| Study type | Interventional |
| Summary | This global platform study will evaluate multiple interventions, across several domains of therapeutic care, in adult patients with kidney failure and newly diagnosed calciphylaxis. |
| Who can participate | Inclusion Criteria: 1. Currently receiving haemodialysis, or peritoneal dialysis that can be converted to haemodialysis, with planned ongoing haemodialysis a minimum of three times per week for at least the duration of the protocolised calciphylaxis treatments within this trial 2. Have a new calciphylaxis ulcer present for less than 10 weeks 3. Age ≥ 18 years 4. Eligible for randomisation in at least one recruiting domain 5. The participant and treating physician are willing and able to perform trial procedures Exclusion Criteria: Nil |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | University of Sydney |
| Locations | Concord, New South Wales, Australia; Kogarah, New South Wales, Australia; Liverpool, New South Wales, Australia; New Lambton Heights, New South Wales, Australia; Westmead, New South Wales, Australia; Birtinya, Queensland, Australia (+15 more sites) |
| Start date | 2021-08-26 |
| NCT ID | NCT05018221 |
| Official listing | https://clinicaltrials.gov/study/NCT05018221 |